NL-OMON27969尚未招募不适用
A placebo-controlled discontinuation trial of off-label used risperidone in people with intellectual disability
niversity Medical Center Groningen (UMCG)0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. IQ<70 as assessed by an authorized behavioral therapist
- •2. Age > 6 years
排除标准
- •1. A history of schizophrenia, a bipolar disorder, or affective psychosis according to DSM IV or ICD-10 criteria
- •2. A history of unsuccessful withdrawal of antipsychotics in the past 6 months
研究者
相似试验
进行中（未招募）
1 期
off-label use of risperidone in people with intellectual disability: A discontinuation studyEUCTR2014-003718-10-NLMCG120
已完成
4 期
A placebo-controlled discontinuation trial of off-label used risperidone in people with intellectual disabilitybehavioral problemsChallenging behavior10037173NL-OMON43644niversitair Medisch Centrum Groningen100
进行中（未招募）
1 期
A Randomized Discontinuation, Blinded, Placebo-Controlled, Phase II Study of Sorafenib in Patients with Chemonaïve Metastatic Uveal Melanoma(Sorafenib Treatment of Metastatic Uveal Melanoma)choroid melanomaMedDRA version: 16.1Level: PTClassification code 10008773Term: Choroid melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022687-12-DEniversitätsklinikum Essen200
招募中
3 期
Efficacy of oral galactose in in Children with multi drug Resistant Nephrotic SyndromeCTRI/2017/12/010830yes
已完成
2 期
A randomised placebo-controlled trial of fixed-dose combination medication in people at raised risk of cardiovascular diseasecardiovascular1001108210003216hypertensionNL-OMON33869niversitair Medisch Centrum Utrecht105